Product Images Egrifta Sv
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 27 images provide visual information about the product associated with Egrifta Sv NDC 62064-241 by Theratechnologies Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Structural Formula - egr00 0001 01
Figure 1 - egr00 0001 02
Figure 2 - egr00 0001 03
Figure A - egr00 0001 04
This appears to be a product packaging for an injection kit. It includes a injection box with bottle cap, rubber stopper, needle cap, needle shield, needle cap, plunger, sterile water, 1mL syringes, 17 20-gauge needles, and 30-gauge needle. The medication box seems to contain a medication called EGRIFTA SV™ in a 2mg/vial strength.*
Figure B - egr00 0001 05
Figure C - egr00 0001 06
Figure D - egr00 0001 07
Figure E - egr00 0001 08
Figure F - egr00 0001 09
Figure G - egr00 0001 10
Figure I - egr00 0001 12
Figure J - egr00 0001 13
Figure K - egr00 0001 14
Figure L - egr00 0001 15
Figure M - egr00 0001 16
Figure N - egr00 0001 17
Figure O - egr00 0001 18
Figure P - egr00 0001 19
Figure Q - egr00 0001 20
Figure R - egr00 0001 21
Figure S - egr00 0001 22
Figure T - egr00 0001 23
Figure U - egr00 0001 24
Figure V - egr00 0001 25
Principal Display Panel - Medication Box - egr00 0001 26
Principal Display Panel - Injection Box - egr00 0001 27
This is a description of an INJECTION BOX for EGRIFTA SV [tesamorolin for injection] 2 mg/vial. The box contains needle, syringes, sterile water for injection, and materials needed for injecting EGRIFTA SV. However, the INJECTION BOX does NOT contain the medication itself. An important note mentions that you should not remove the contents until you have the EGRIFTA SV 2 mg/vial medication BOX.*
Principal Display Panel - 2 mg Vial Label - egr00 0001 28
This is a medication called EGRIFTASV containing tesamorelin acetate that is injected subcutaneously to treat a specific condition. Each vial contains 2 mg of the medication and is for single-use. The instructions for use should be followed carefully, and any unused medication should be discarded. The medication is distributed by Theratechnologies Inc. Lot and expiration information is provided for tracking and reference purposes.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.